Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04748965 · ClinicalTrials.gov registry record

Imaging-Guided Vessel Sizing in the Tibial Arteries

A clinical trial of Peripheral Artery Disease and Critical Limb Ischemia, sponsored by University Hospitals Cleveland Medical Center.

Completed
Registry status
40
Enrollment target
3
Study locations

NCT04748965 is a study of Peripheral Artery Disease and Critical Limb Ischemia that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 40 participants, below the 126-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (68% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04748965, a study of Peripheral Artery Disease and Critical Limb Ischemia, has completed, sponsored by University Hospitals Cleveland Medical Center.

COMPLETED
Registry status
40 participants
Enrollment target
3
Study locations

Study Summary

This study aims to investigate the utilization of intravascular imaging in treatment of tibial vessels in peripheral artery disease and critical limb ischemia (CLI). The primary goal is to compare optical coherence tomography (OCT) with traditional digital subtraction angiography (DSA) in determining best treatment strategy and vessel optimization, in an effort to improve long term patency and successful wound healing in CLI. Secondary comparison with intravascular ultrasound (IVUS) is undertaken when clinically feasible. The hypothesis is that the adjunctive use of intravascular imaging will affect vessel sizing and anticipated treatment modalities, and therein affect the long term primary patency rates.

Conditions Studied

Peripheral Artery Disease Critical Limb Ischemia

Interventions

  • DIAGNOSTIC_TEST Digital Subtraction Angiography

Study Locations (3)

Ohio

  • University Hospitals Ahuja Medical Center - Beachwood
  • University Hospitals Cleveland Medical Center - Cleveland
  • University Hospitals Parma Medical Center - Parma

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-08-16
Est. Completion 2024-06-09

Sponsor

University Hospitals Cleveland Medical Center

230 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04748965

The ClinicalTrials.gov registry entry for NCT04748965 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 126-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (68% lower). The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Peripheral Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Digital Subtraction Angiography is the first listed.

NCT04748965 reports 3 study locations spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04748965 about?

NCT04748965 is a clinical study titled "Imaging-Guided Vessel Sizing in the Tibial Arteries". This study aims to investigate the utilization of intravascular imaging in treatment of tibial vessels in peripheral artery disease and critical limb ischemia (CLI). The primary goal is to compare optical coherence tomography (OCT) with traditional digital subtraction angiography (DSA) in determinin...

What is the current status of trial NCT04748965?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2021-08-16. Estimated completion is 2024-06-09.

What conditions does trial NCT04748965 study?

This clinical trial studies the following conditions: Peripheral Artery Disease, Critical Limb Ischemia.

What interventions are being tested in trial NCT04748965?

The interventions under investigation include: Digital Subtraction Angiography (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04748965?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04748965 being conducted?

This trial has 3 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Peripheral Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Peripheral Artery Disease

All registered trials for this condition

Critical Limb Ischemia

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.